ITMCTR2000003945Not yet recruitingPhase 1
A multicenter study on the efficacy and influencing factors of insect drug compound in the treatment of MMR related stage III colorectal cancer
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Not yet recruiting
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional study
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •(1) According to the above diagnostic criteria, the patient was diagnosed as stage III colorectal cancer;
- •(2) Patients who agreed to undergo radical surgery and were confirmed by histopathology as TN1-2M0 and MMR detected by immunohistochemistry;
- •(3) Aged >=18 years;
- •(4) Patients with expected survival time >=6 months; ECoG <=2;
- •(5) The patient agreed to be followed up;
- •(6) The follow-up and clinical data will be complete;
- •(7) Patients voluntarily sign informed consent.
Exclusion Criteria
- •(1) Complicated with other primary malignant tumor;
- •(2) Complicated with serious heart, brain, liver, kidney disease, electrolyte abnormality or mental illness;
- •(3) Patients who are allergic to the drugs used in this study or their ingredients;
- •(4) Pregnancy, lactation or planned pregnancy;
- •(5) There are serious or uncontrollable infections;
- •(6) Those who took other traditional Chinese medicine or participated in other clinical trials in recent 2 weeks.
Investigators
Similar Trials
Not yet recruiting
Phase 1
A multicenter study on the efficacy and influencing factors of Insect Compound Particle in the treatment of MMR related stage III colorectal cancercolorectal cancerITMCTR2000003835Shanghai Municipal Hospital of Traditional Chinese Medicine
Completed
Not Applicable
Investigating the effect and safety of the Satisphere™ insert in overweight patientsObesityISRCTN81340421Endosphere Inc (USA)60
Recruiting
Phase 2
A Clinical Trial to study the effects of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral ConjunctivitisCTRI/2012/11/003145ovaBay Pharmaceutical Inc440
Completed
Not Applicable
A Clinical Trial to study the effects of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral ConjunctivitisAdenoviral ConjunctivitisSLCTR/2013/026ovaBay Pharmaceutical, Inc
Recruiting
Unknown
A multicenter observational study on the efficacy and safety of systemic therapy for hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000053532Kyoto University750